Indivior | Driftskostnader



Operating Expenses Endring Dato
AstraZeneca USD 12.86B 2.06B 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
Glaxosmithkline GBP 7.42B 408M 2024-12
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Indivior 213M 218M 2024-09
J&J USD 18.63B 500M 2024-12
Kyowa Hakko Kirin JPY 102.9B 107M 2024-09
Merck USD 11.33B 1.4B 2024-12
Novartis USD 10.15B 579M 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Sanofi EUR 6.77B 3.75B 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12



Indivior Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.